An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

NCT02192697 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
124
Enrollment
INDUSTRY
Sponsor class

Stopped Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies.

Conditions

Interventions

Sponsor

Astellas Pharma Inc